Comment on: Sodium-glucose co-transporter-2 inhibitors and risk of adverse renal outcomes among type 2 diabetes patients: A network and cumulative meta-analysis of randomized controlled trials

Diabetes Obes Metab. 2017 Dec;19(12):1823. doi: 10.1111/dom.13035. Epub 2017 Jul 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Randomized Controlled Trials as Topic*
  • Sodium
  • Sodium-Glucose Transporter 2

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2
  • Sodium
  • Glucose